Okamoto, Kento
Ando, Toshinori http://orcid.org/0000-0002-3141-8173
Izumi, Hiroki
Kobayashi, Susumu S.
Shintani, Tomoaki http://orcid.org/0000-0002-0789-3273
Gutkind, J. Silvio
Yanamoto, Souichi
Miyauchi, Mutsumi
Kajiya, Mikihito
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP20K18477, JPMJSP2132)
“Nozomi h foundation” from the Hiroshima University Foundation the JST HIRAKU-Global program
Article History
Received: 6 February 2023
Revised: 1 August 2023
Accepted: 9 August 2023
First Online: 17 August 2023
Competing interests
: JSG is a member of the advisory board of Domain Therapeutics, io9, and Pangea, and founder of Kadima Pharmaceuticals. The remaining authors declare no conflicts of interest.